Beijing: Chinese health experts are warning that counterfeit versions of Indian generics are flooding the black market in China as a record wave of COVID-19 cases fuels demand for antivirals, particularly Pfizer’s Paxlovid and Indian generic versions. With the huge demand for COVID-19 medication, some fake